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Abstract
The diaphragm is a crucial muscle involved in active inspiration and whole body homeostasis. Previous biochemical, immu-
nochemical and cell biological investigations have established the distribution and fibre type-specific expression of key 
diaphragm proteins. Building on these findings, it was of interest to establish the entire experimentally assessable diaphragm 
proteome and verify the presence of specific protein isoforms within this specialized subtype of skeletal muscle. A highly 
sensitive Orbitrap Fusion Tribrid mass spectrometer was used for the systematic identification of the mouse diaphragm-
associated protein population. Proteomics established 2925 proteins by high confidence peptide identification. Bioinfor-
matics was used to determine the distribution of the main protein classes, biological processes and subcellular localization 
within the diaphragm proteome. Following the establishment of the respiratory muscle proteome with special emphasis on 
protein isoform expression in the contractile apparatus, the extra-sarcomeric cytoskeleton, the extracellular matrix and the 
excitation–contraction coupling apparatus, the mass spectrometric analysis of the diaphragm was extended to the refined 
identification of proteome-wide changes in X-linked muscular dystrophy. The comparative mass spectrometric profiling of 
the dystrophin-deficient diaphragm from the mdx-4cv mouse model of Duchenne muscular dystrophy identified 289 decreased 
and 468 increased protein species. Bioinformatics was employed to analyse the clustering of changes in protein classes and 
potential alterations in interaction patterns of proteins involved in metabolism, the contractile apparatus, proteostasis and the 
extracellular matrix. The detailed pathoproteomic profiling of the mdx-4cv diaphragm suggests highly complex alterations 
in a variety of crucial cellular processes due to deficiency in the membrane cytoskeletal protein dystrophin.
Keywords Diaphragm · Duchenne muscular dystrophy · Dystrophin · Dystrophinopathy · Mdx-4cv mouse · Skeletal muscle 
proteome
Introduction
In mammalians, bronchoalveolar function and efficient gas-
exchange in the lungs is intrinsically coupled to the con-
tractile activity of the diaphragm (Kocjan et al. 2017). The 
specialized diaphragm muscle, which anatomically separates 
the abdominal and thoracic cavity, is essential for respiration 
and acts as the primary contractile force of active inspira-
tion. In addition, the diaphragm is involved in the function-
ing of the vascular and lymphatic systems, supports postural 
control via stabilisation of the lumbar spine during loading 
work, and contributes to essential gastroesophageal func-
tions and its reflux barrier (Bordoni and Zanier 2013). The 
specialized task of continuous contractile performance by 
the diaphragm is reflected by the physiological resistance 
to fatigue, the high density of capillaries and an elevated 
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aerobic oxidative capacity. Pathological changes in the 
diaphragm muscle have devastating effects on the overall 
physiological homeostasis in the body. In Duchenne mus-
cular dystrophy, an X-linked neuromuscular disorder with a 
highly progressive muscle wasting aetiology, the diaphragm 
is severely affected and causes respiratory deficiencies (Khi-
rani et al. 2014).
With the rapid advances of systems biological approaches 
in the field of skeletal muscle biology (Smith et al. 2013), it 
is now possible to routinely determine large-scale changes 
at the level of the transcriptome, proteome and metabolome 
in adapting or diseased muscle tissues. Although mass spec-
trometry-based proteomics has been widely applied to the 
comparative analysis of the diaphragm (Matsumura et al. 
2013; Sollanek et al. 2017; Kelley et al. 2018), the establish-
ment of a comprehensive proteomic databank for diaphragm 
has not yet been fully realized. However, using liquid chro-
matography and/or gel electrophoretic techniques (Murphy 
et al. 2016), general skeletal muscle proteomics has made 
enormous progress in the systematic cataloguing of assess-
able muscle protein populations from muscle cell lines, as 
well as select muscles from humans and animal models 
(Dowling et al. 2016; Capitanio et al. 2017; Gonzalez-Freire 
et al. 2017), and has identified over 10,000 muscle-associ-
ated protein species (Højlund et al. 2008; Parker et al. 2009; 
Deshmukh et al. 2015). The complexity of bioenergetic pro-
cesses and mitochondrial specialization in skeletal muscles 
was verified by single fibre proteomics (Murgia et al. 2015).
Building on these findings from biochemical profiling 
studies of skeletal muscle tissue, in this report we describe 
the proteomic and bioinformatic analysis of the adult mouse 
diaphragm, using an Orbitrap Fusion Tribrid mass spectrom-
eter, with special focus on protein isoform expression in the 
contractile apparatus, the extra-sarcomeric cytoskeleton, the 
extracellular matrix and the excitation–contraction coupling 
apparatus. Following the establishment of the assessable dia-
phragm proteome, a comparative approach was used for the 
refined identification of proteomic alterations in the mdx-4cv 
mouse model of Duchenne muscular dystrophy. X-linked 
muscular dystrophy is due to primary abnormalities in the 
Dmd gene and represents the most frequently inherited 
neuromuscular disorder of early childhood (Guiraud et al. 
2015). Dystrophinopathies are characterized by a complex 
multi-system pathology including progressive fibre degen-
eration, fatty tissue replacement and reactive myofibrosis 
(Ohlendieck and Swandulla 2017), as well as severe impair-
ments of ion homeostasis and cellular signalling mecha-
nisms (Allen et al. 2016) and sterile inflammation (Tidball 
et al. 2018).
In addition, cardiac impairment and respiratory muscle 
decline are hallmarks of X-linked muscular dystrophy (Khi-
rani et al. 2014; Hor et al. 2018). Diaphragm muscle weak-
ness is intrinsically involved in sleep disordered breathing 
in Duchenne patients, especially when the diaphragm has to 
provide most of the ventilation during the rapid eye move-
ment sleep phase of maximal muscle hypotonia (LoMauro 
et al. 2017). Importantly, the diaphragm in the mdx mouse 
model of dystrophinopathy shows a pathological pattern of 
fibre degeneration, myofibrosis, inflammation and severe 
functional deficit comparable to that seen in Duchenne 
patients (Stedman et al. 1991; Ishizaki et al. 2008; Coirault 
et al. 2003), making mdx-type diaphragm muscles highly 
suitable for studying the pathobiochemical consequences 
of the almost complete loss of the membrane cytoskeletal 
protein dystrophin and its associated glycoprotein complex 
(Murphy and Ohlendieck 2015). The systematic analysis of 
dystrophinopathy-associated changes presented here sug-
gests drastic changes in the abundance and interaction pat-
terns of a large variety of diaphragm proteins involved in 
energy metabolism, the excitation-contraction-relaxation 




A variety of general analytical grade reagents and materials 
were used for the proteomic profiling of mouse diaphragm 
muscle, as well as the comparative mass spectrometric sur-
vey of diaphragm preparations from wild type versus dys-
trophic mdx-4cv mice. These reagents were obtained from 
GE Healthcare (Little Chalfont, Buckinghamshire, UK), 
Bio-Rad Laboratories (Hemel-Hempstead, Hertfordshire, 
UK) and Sigma Chemical Company (Dorset, UK). Sequenc-
ing grade modified trypsin was purchased from Promega 
(Madison, WI, USA) and Whatman nitrocellulose transfer 
membranes came from Invitrogen (Carlsbad, CA, USA). 
The chemiluminescence substrate and protease inhibitors 
were obtained from Roche Diagnostics (Mannheim, Ger-
many). The primary antibodies to dystrophin and carbonic 
anhydrase isoform CA3 were from Leica Biosystems, Wet-
zlar, Germany (antibody NCL-DYS1 [clone Dy8/6C5]) and 
Abcam, Cambridge, UK (antibody ab118428), respectively. 
For immunofluorescence microscopy, normal goat serum 
and anti-mouse and anti-rabbit IgG (Alexa Fluor 488 and 
Alexa Fluor 568) were purchased from Molecular Probes, 
Life Technologies (Darmstadt, Germany) and Jackson 
ImmunoResearch (West Grove, PA, USA), respectively. The 
embedding medium Fluoromount G was from Southern Bio-
tech (Birmingham, AL, USA).
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Genetic mdx‑4cv mouse model of Duchenne 
muscular dystrophy
The mdx-4cv mouse model is one of four chemical variants 
of the spontaneous mdx mutant, generated on the C57/BL6 
background by chemical mutagenesis using N-ethyl-nitros-
ourea (Chapman et al. 1989). The resulting C to T transition 
in exon 53 of the Dmd gene introduces a premature stop 
codon. For the generation of a proteomic map of wild type 
diaphragm and for the identification of global proteomic 
alterations in the dystrophin-deficient diaphragm, whole 
diaphragms from 10-month old control C57/BL6 mice and 
age-matched mdx-4cv mice were obtained from the Biore-
source Unit of the University of Bonn. Mice were kept under 
standard conditions and all procedures adhered to German 
legislation on the use of animals in experimental research. 
The animals were sacrificed by cervical dislocation and dia-
phragms were carefully dissected and quick-frozen in liquid 
nitrogen. Samples were transported to Maynooth University 
in accordance with the Department of Agriculture (animal 
by-product register number 2016/16 to the Department of 
Biology, National University of Ireland, Maynooth) on dry 
ice and stored at − 80 °C prior to analysis.
Preparation of diaphragm homogenates from wild 
type versus dystrophic mice
Following an optimization phase for protein extraction from 
diaphragm homogenates, proteomic analyses were carried 
out with protein populations derived from the preparation 
of whole diaphragms (with an average weight of 150 mg). 
Tissue specimens from 10-month old wilde type mice (n = 4) 
and age-matched mdx-4cv mice (n = 4) were finely chopped 
and homogenised in 1 ml of lysis buffer (6M urea, 2M thio-
urea, supplemented with a protease inhibitor cocktail), using 
a hand-held IKA T10 Basic Homogeniser (IKA Labortech-
nik, Staufen, Germany). Homogenates were kept on ice 
for 2 h and were subsequently centrifuged at 14,000×g for 
20 min at 4 °C (Holland et al. 2015a). The protein con-
taining supernatant was removed and used for comparative 
proteomic analysis.
Sample preparation for label‑free liquid 
chromatography mass spectrometry
Protein concentrations were determined by the Bradford 
method (Bradford 1976) and concentrations were then 
equalised with lysis buffer. 30 µg of protein was processed 
by the FASP (filter aided sample preparation) method 
(Wiśniewski et al. 2009) using a trypsin to protein ratio of 
1:25 (protease:protein). Following overnight digestion and 
elution of peptides from the spin filter, 2% trifluoroacetic 
acid (TFA) in 20% acetonitrile (ACN) was added to the 
filtrates [3:1 (v/v) dilution]. The peptides were then purified 
using Pierce C18 spin columns from Thermo Fisher Sci-
entific (Dublin, Ireland), dried through vacuum centrifuga-
tion and re-suspended in mass spectrometry loading buffer. 
Peptides were vortexed, sonicated and briefly centrifuged at 
14,000×g and the supernatant transferred to mass spectrom-
etry vials for label-free LC–MS/MS analysis.
Label‑free liquid chromatography mass 
spectrometry
As recently outlined in detail (Murphy et al. 2018), reverse-
phased capillary high pressure liquid chromatography was 
carried out using the UltiMate 3000 nano system (Thermo 
Scientific) coupled directly in-line with the Thermo Orbit-
rap Fusion Tribrid Mass Spectrometer (Thermo Scientific). 
The digested samples were loaded onto the trapping column 
(PepMap100, C18, 300 µm × 5 mm) at a flow rate of 25 µL/
min with 2% (v/v) acetonitrile (ACN), 0.1% (v/v) trifluoro-
acetic acid (TFA) for 3 min before being resolved onto an 
analytical column (Acclaim PepMap 100, 75 µm × 50 cm, 
3 µm bead diameter column). Peptides were eluted using the 
following binary gradient; solvent A (0.1% (v/v) formic acid 
in LC-MS grade water) and 2-27.5% solvent B (80% (v/v) 
ACN, 0.08% (v/v) formic acid in LC-MS grade water) for 
110 min at a flow rate of 300 nL/min. For peptide ionization, 
a voltage of 1.9 kV was applied and a capillary tempera-
ture of 320 °C was used. Data-dependent acquisition with 
full scans in the 375–1500 m/z range was performed using 
an Orbitrap mass analyser with a resolution of 120,000 (at 
m/z 200), a targeted automatic gain control (AGC) value 
of 4E + 05 and a maximum injection time of 50 ms. The 
number of selected precursor ions for fragmentation was 
determined by the top-speed acquisition algorithm. Selected 
precursor ions were isolated in the Quadrupole with an isola-
tion width of 1.6 Da. Peptides with a charge state of 2 + to 
6 + were analysed and a dynamic exclusion was applied after 
60 s. Precursor ions were fragmented using higher energy 
collision-induced dissociation (HCD) with a normalized 
collision energy of 28%, and resulting MS/MS ions were 
measured in the linear ion trap. The typical MS/MS scan 
conditions were as follows: a targeted AGC value of 2E + 04 
and a maximum fill time of 35 ms.
Protein profiling by label‑free liquid 
chromatography tandem mass spectrometry
Qualitative data analysis was used to characterise the pro-
teome of wild type diaphragm muscle. MS raw files from 
label-free liquid chromatography tandem mass spectrom-
etry (LC-MS/MS) analysis were processed using the Pro-
teome Discoverer 1.4 (Thermo Fisher Scientific) software 
with Sequest HT as the search engine and the Mus musculus 
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UniProtKB-SwissProt sequence database. The following 
search parameters were used for protein identification: (1) 
peptide mass tolerance set to 10 ppm, (2) MS/MS mass tol-
erance set to 0.6 Da, (3) up to two missed cleavages, (4) 
carbamidomethylation set as a fixed modification and (5) 
methionine oxidation set as a variable modification. Peptides 
were filtered using a minimum XCorr score of 1.5 for + 1, 
2.0 for + 2, 2.25 for + 3 and 2.5 for + 4 charge states, with 
peptide probability set to high confidence.
Progenesis QI for Proteomics software (version 3.1; 
Non-Linear Dynamics, a Waters company, Newcastle upon 
Tyne, UK) was used for the quantitative analysis of dia-
phragm from wild-type versus mdx-4cv mice. To account 
for potential drifts in retention time, all runs were aligned 
to a reference run. The following settings were used to filter 
peptide features: (1) peptide features with ANOVA ≤ 0.05 
between experimental groups, (2) mass peaks with charge 
states from + 1 to + 4 and (3) greater than one isotope per 
peptide (Murphy et al. 2018). A Mascot generic file (mgf) 
was generated from all exported MS/MS spectra which was 
used for peptide and protein identification via Proteome Dis-
coverer 2.1 (Thermo Scientific) using Sequest HT against 
the UniProtKB-SwissProt Mus musculus database. The fol-
lowing search parameters were used: (1) peptide mass toler-
ance set to 10 ppm, (2) MS/MS mass tolerance set to 0.6 Da, 
(3) up to two missed cleavages, (4) carbamidomethylation 
set as a fixed modification and (5) methionine oxidation 
set as a variable modification. For re-importation back into 
Progenesis LC-MS software as a PepXML file only highly 
confident peptides with a FDR of ≤0.01 as determined by 
Percolator validation in Proteome Discoverer were allowed 
(O’Sullivan et al. 2017). The following criteria were applied 
to assign proteins as positively identified: (1) an ANOVA 
score between experimental groups of ≤ 0.05, (2) proteins 
with ≥ 2 unique peptides matched and (3) a fold change ≥ 
1.5.
A heat map illustrating protein abundances for statisti-
cally significant differentially abundant proteins with a fold 
change of 2 or more was designed using Perseus software. 
The normalised abundances of differentially abundant 
proteins determined using Progenesis QI for Proteomics 
were loaded as a txt file into Perseus and the data was log2 
transformed. Hierarchical clustering was then performed 
on Z-score normalised intensity values by clustering both 
samples and proteins using Euclidean distance and average 
linkage.
Bioinformatics analysis
In order to group identified diaphragm proteins based on 
their protein class and to identify potential protein–protein 
interaction patterns, publically available bioinformatics soft-
ware programmes were employed. Bioinformatics analysis 
was performed with datasets from both the assessable total 
mouse diaphragm proteome and identified proteins with a 
changed concentration in the dystrophic mdx-4cv diaphragm. 
The programs used were the DAVID (version 6.8.) bioin-
formatics resource for the identification of enriched gene 
ontology terms (https ://david .ncifc rf.gov), the PANTHER 
database of protein families (Mi et al. 2017; http://panth erdb.
org/) and the STRING database of known and putative pro-
tein interactions that include both direct physical and indi-
rect functional protein associations (Szklarczyk et al. 2017; 
http://strin g-db.org/). KEGG colour pathway analysis of the 
dystrophic mdx-4cv diaphragm was carried out with a focus 
on proteins involved in oxidative phosphorylation using 
the Kyoto Encyclopedia of Genes and Genomes databank 
(Kanehisa et al. 2017; https ://www.genom e.jp/kegg).
Comparative histology and immunofluorescence 
microscopy
Characteristic histopathological changes and reduction of 
the dystrophin isoform Dp427-M in the diaphragm of the 
genetic mdx-4cv mouse model of Duchenne muscular dystro-
phy was carried out with routine histological haematoxylin 
and eosin staining and immunofluorescence microscopy, as 
previously described in detail (Murphy et al. 2019b). Freshly 
dissected diaphragm muscle specimens from 12-month 
mdx-4cv versus wild type mice were quick-frozen in liq-
uid nitrogen-cooled isopentane and 10 µm sections cut in a 
cryostat. For dystrophin immuno-staining, unfixed cryosec-
tions were boiled in phosphate-buffered saline for 5 min. Pri-
mary antibodies to dystrophin were diluted appropriately in 
phosphate-buffered saline for overnight incubation at 4 °C. 
Tissue specimens were then washed and incubated with a 
secondary fluorescently-labelled anti-mouse antibody for 
45 min at room temperature. Fluorescent labeling of tissue 
sections for carbonic anhydrase was carried out in a similar 
manner, but with secondary anti-rabbit antibodies. Nuclei 
were counter-stained with 1 µg/ml bis-benzimide Hoechst 
33342. Antibody-labelled muscle tissue sections were 
embedded in Fluoromount G medium and viewed under 
a Zeiss Axioskop 2 epifluorescence microscope equipped 
with a digital Zeiss AxioCam HRc camera (Carl Zeiss Jena 
GmbH, Jena, Germany).
Results
Proteomic profiling of the mouse diaphragm muscle
With the help of an Orbitrap Fusion Tribrid mass spectrom-
eter, the assessable proteome of 10-month old mouse dia-
phragm muscle was catalogued. The proteomic screening 
approach identified 2925 diaphragm-associated proteins 
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using multi-consensus data files from the analysis of eight 
separate mass spectrometric sample runs (four biological 
repeats and two technical repeats) consisting of high con-
fidence peptides that were filtered based on Xcorr values. 
The data underlying the cataloguing of the diaphragm mus-
cle has been deposited to the Open Science Framework (17 
files under the project title ‘Proteomic profile of mouse dia-
phragm muscle’; https ://osf.io/mxfc9 /?view_only=9a321 
60f87 6f42b b813d a4886 7457d 6c;Date created: 2018-07-
23; project description: the data here is 16 raw files from 
the LC-MS/MS analysis of wild-type and mdx-4cv crude 
diaphragm homogenates (four biological repeats, two tech-
nical repeats). Also shown is the Proteome Discoverer mul-
ticonsensus report of the eight wild type diaphragm mass 
spectrometry raw files).
The quality of the proteomic findings was demonstrated 
by the wide range of identified proteins and the high per-
centage of sequence coverage of typical skeletal muscle-
associated protein species. The list of identified proteins 
ranged from very small proteins (60S ribosomal protein 
L38 of 8 kDa; 45.7% coverage; 4 unique peptides) to small 
proteins (muscle-specific myosin light chain MLC1/3 of 
21 kDa; 90.4% coverage; 14 unique peptides) to medium-
size proteins  (Ca2+-ATPase isoform SERCA1 of 109 kDa; 
47.9% coverage; 35 unique peptides) to large proteins (full-
length dystrophin isoform Dp427-M of 426 kDa; 32.5% cov-
erage; 90 unique peptides) to giant muscle proteins (titin of 
3904 kDa; 53.1% coverage; 1299 unique peptides).
In below sections, individual tables list the proteomic 
identification of select markers of the contractile apparatus 
and its associated sarcomeric structures, the extra-sarco-
meric cytoskeleton including the dystrophin–glycoprotein 
complex, the extracellular matrix and the excitation–contrac-
tion coupling and ion-handling apparatus. Pathobiochemical 
changes in these cellular structures and mechanisms are of 
central importance for our understanding of the molecu-
lar pathogenesis of neuromuscular diseases, and will be 
discussed in this report in relation to X-linked muscular 
dystrophy.
Bioinformatics analysis of the assessable mouse 
diaphragm
Information on the total number of identified diaphragm 
proteins in relation to their sequence coverage by numbers 
of unique peptides is provided in Fig. 1. Bioinformatics 
analysis was carried out with 1,908 proteins that had been 
identified by 2 or more unique peptides. The overview of the 
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Identification of mouse diaphragm proteins
using peptide mass spectrometry
Fig. 1  Proteomic profile of the mouse diaphragm muscle. Shown is 
an overview of the identification of mouse diaphragm proteins using 
peptide mass spectrometry, as well as findings from the bioinformat-
ics analysis of the distribution of biological processes and the subcel-
lular localization of identified diaphragm proteins
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distribution of individual protein members of the assessable 
diaphragm proteome shows a broad spectrum of involve-
ments in biological processes and a variety of localizations 
in subcellular structures. A large number of diaphragm pro-
teins was shown to be functionally linked to metabolism, 
regulation, signalling and cellular organization, and being 
located in various membranes, a large number of organelles 
including mitochondria, sarcoplasmic reticulum, Golgi 
apparatus and endosomes, as well as macromolecular com-
plexes, cytoskeletal systems and the extracellular matrix 
(Fig. 1).
The PANTHER analysis of the mouse diaphragm pro-
teome, shown in Fig. 2, gives an overview of the 25 most 
common protein classes present in the proteome of this 
contractile tissue. The classification revealed that a large 
number of identified diaphragm proteins belong to the class 
of hydrolases, nucleic acid binding proteins, oxidoreduc-
tases, transferases, enzyme modulators and cytoskeletal 
components.
Proteomic map of the contractile apparatus
As listed in detail in Table 1, the proteomic profiling of the 
wild type mouse diaphragm established the presence of the 
main isoforms of myosin heavy chain, including MyHC-
2x, MyHC-3, MyHC-2b, MyHC-slow and MyHC-perina-
tal, the main isoforms of myosin light chain, muscle MLC 
kinase and myosin-binding proteins. Key components of the 
actin filament were also clearly identified by proteomics, 
including α-actin, the troponin complex, tropomyosins and 
F-actin-capping protein. Major constituents of the Z-disk 
complex, the M-band and the titin filament were shown to 
be present in the diaphragm extracts.
Proteomic map of the extra‑sarcomeric cytoskeletal 
network
The main components of the extra-sarcomeric network of 
cytoskeletal proteins have been identified by the proteomic 
screening of mouse diaphragm and are listed in Table 2. This 
includes the main protein classes involved in the structural 
stabilisation and maintenance of intermediate filaments, 
the intracellular actin cytoskeleton and membrane-associ-
ated cytoskeletal systems. The core members of the dystro-
phin–glycoprotein complex were shown to be present in the 
analysed diaphragm extract. This included the full-length 
muscle dystrophin isoform Dp427-M and the members 
of the α/β-dystroglycan subcomplex, as well as α/β/γ/δ-
sarcoglycans, syntrophin and dystrobrevin.
Proteomic map of the extracellular matrix
The mass spectrometric survey of mouse diaphragm extracts 
presented in this study identified various laminins and the 
basement membrane-specific heparan sulfate proteoglycan 
core protein, both major components of the basal lamina. 
The main structural protein of the extracellular matrix, 
collagen, was confirmed to exist in a plethora of isoform 
Fig. 2  Summary of protein 
classes in the mouse diaphragm 
muscle. The bioinformatics 
software programme PAN-
THER was employed to sum-
marize the clustering of protein 
classes based on the mass 
spectrometric analysis of wild 
type mouse diaphragm
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Table 1  Proteomic profile of 
the contractile apparatus and 
associated sarcomeric proteins 
of mouse diaphragm muscle
Accession Protein name Gene name Coverage % Unique Peptides Peptides
Q5SX40 Myosin-1, MyHC-2x Myh1 69.57 46 185
P13541 Myosin-3, MyHC-3 Myh3 26.55 5 71
Q5SX39 Myosin-4, MyHC-2b Myh4 66.32 34 168
Q91Z83 Myosin-7, MyHC-slow Myh7 65.27 100 153
P13542 Myosin-8, MyHC-perinatal Myh8 47.96 6 127
P05977 Myosin light chain MLC1/MLC3 Myl1 90.43 14 18
P97457 Myosin light chain MLC2, muscle Mylpf 86.39 15 15
P51667 Myosin light chain MLC2, slow Myl2 86.14 14 14
P09542 Myosin light chain MLC3, slow Myl3 78.43 13 17
Q8VCR8 Myosin light chain kinase 2 Mylk2 22.84 7 8
Q5XKE0 Myosin-binding protein MyBP-C Mybpc2 52.38 49 49
P70402 Myosin-binding protein MyPB-H Mybph 18.43 5 5
P68134 Actin, alpha skeletal muscle Acta1 73.74 3 26
P20801 Troponin TnC, muscle Tnnc2 52.50 6 7
P19123 Troponin TnC, slow muscle Tnnc1 47.20 6 6
O88346 Troponin TnT, slow muscle Tnnt1 45.80 9 12
Q9QZ47 Troponin TnT, fast muscle Tnnt3 43.93 14 17
Q9WUZ5 Troponin TnI, slow muscle Tnni1 36.36 7 7
P13412 Troponin TnI, fast muscle Tnni2 32.42 8 8
P58771 Tropomyosin, alpha-1 Tpm1 67.61 3 31
P58774 Tropomyosin, beta Tpm2 69.72 5 28
P21107 Tropomyosin, alpha-3 Tpm3 64.56 7 27
Q6IRU2 Tropomyosin, alpha-4 Tpm4 39.11 8 12
Q7TPR4 Alpha-actinin-1 ACTN1 39.91 14 32
Q9JI91 Alpha-actinin-2 Actn2 75.95 39 57
O88990 Alpha-actinin-3 ACTN3 66.33 37 51
P57780 Alpha-actinin-4 Actn4 55.92 25 39
P47753 F-actin-capping protein, alpha-1 Capza1 25.17 2 4
P47754 F-actin-capping protein, alpha-2 Capza2 58.39 8 10
P47757 F-actin-capping protein, beta Capzb 37.91 11 11
Q8VHX6 Filamin-C, muscle Flnc 53.01 91 102
Q02357 Ankyrin-1 Ank1 12.04 6 12
Q8C8R3 Ankyrin-2 Ank2 1.69 3 5
O70548 Telethonin Tcap 17.96 3 3
Q62234 Myomesin-1 Myom1 62.33 2 88
A2ABU4 Myomesin-3 Myom3 50.03 54 54
P49813 Tropomodulin-1 Tmod1 32.59 7 8
Q9JLH8 Tropomodulin-4 Tmod4 40.00 11 12
Q9JK37 Myozenin-1 Myoz1 75.00 12 12
Q9JJW5 Myozenin-2 Myoz2 70.83 15 15
Q8R4E4 Myozenin-3 Myoz3 36.73 6 6
Q5DTJ9 Myopalladin Mypn 11.63 13 13
O70373 Xin actin-binding protein 1 Xirp1 12.75 10 10
Q4U4S6 Xin actin-binding protein 2 Xirp2 4.57 11 11
A2ASS6 Titin Tnt 53.08 1299 1451
Q80XB4 Nebulin-related-anchoring protein Nrap 16.01 22 22
A2AAJ9 Obscurin Obscn 31.13 157 157
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chains (Table 3). Various members of the proteoglycan net-
work were identified as belonging to the families of small 
leucine-rich repeat proteins and proline-arginine-rich and 
leucine-rich repeat proteins. In addition, the regulatory pro-
teins dermatopontin, nidogen and periostin, as well as the 
transmembrane receptor integrin and its coupling proteins 
fibronectin and vitronectin were identified to be present in 
the assessable diaphragm proteome.
Proteomic map of the excitation–contraction 
coupling apparatus
The main regulatory proteins involved in excitation–con-
traction coupling were identified in the assessable mouse 
diaphragm proteome, including the main muscle isoform 
RyR1 of the ryanodine receptor  Ca2+-release channel of the 
triad junction, and the α-1S, α-2/δ-1 and β-1 subunits of 
the voltage-dependent L-type calcium channel of the trans-
verse tubules (Table 4). The mass spectrometric survey also 
revealed the presence of the crucial  Ca2+-binding proteins 
calsequestrin, sarcalumenin, regucalcin, and calmodulin, as 
well as the  Ca2+/calmodulin-dependent protein kinase and 
structural triad components such as triadin and junctophi-
lins. Ion-pumping ATPases involved in the regulation of 
skeletal muscle relaxation and ion movements through the 
sarcolemma, as well as the propagation of action potential 
and the continuous maintenance and restoration of the rest-
ing membrane potential were also identified in diaphragm 
extracts.
Comparative proteomic and bioinformatic analysis 
of the dystrophic mdx‑4cv diaphragm
Following the establishment of the assessable diaphragm 
proteome, we carried out a comparative proteomic analysis 
of the dystrophic mdx-4cv mouse model of dystrophinopathy 
that is characterized by the almost complete absence of the 
membrane cytoskeletal protein dystrophin. Characteristic 
histopathological changes in the dystrophic diaphragm, such 
as a higher frequency of central nuclei, an increased number 
Table 2  Proteomic map of the 
dystrophin complex and the 
extra-sarcomeric cytoskeletal 
network from diaphragm muscle
Accession Protein name Gene name Coverage % Unique 
peptides
Peptides
P11531 Dystrophin, Dp427-M Dmd 32.46 90 90
Q62165 Dystroglycan, alpha/beta Dag1 7.61 6 6
P82350 Sarcoglycan, alpha Sgca 20.41 6 6
P82349 Sarcoglycan, beta Sgcb 29.38 7 7
P82348 Sarcoglycan, gamma Sgcg 21.31 4 4
P82347 Sarcoglycan, delta Sgcd 24.91 6 6
Q61234 Syntrophin, alpha-1 Snta1 34.59 10 10
Q61235 Syntrophin, beta-2 Sntb2 5.19 3 3
Q9D2N4 Dystrobrevin, alpha Dtna 13.06 6 6
P20152 Vimentin Vim 72.96 30 36
P31001 Desmin Des 72.07 28 33
Q64727 Vinculin Vcl 46.90 38 38
P68134 Actin, alpha skeletal muscle Acta1 73.74 3 26
P62737 Actin, aortic smooth muscle Acta2 73.74 3 25
P60710 Actin, cytoplasmic 1 Actb 59.20 6 20
P16546 Spectrin alpha, non-erythrocytic 1 Sptan1 46.94 83 84
Q62261 Spectrin beta, non-erythrocytic 1 Sptbn1 37.11 61 63
P08032 Spectrin alpha, erythrocytic 1 Spta1 18.47 30 31
P15508 Spectrin beta chain, erythrocytic Sptb 31.06 47 49
Q9QXS1 Plectin, isoform PLEC-1D Plec 53.82 213 213
Q70IV5 Synemin Synm 41.46 37 37
P05213 Tubulin, alpha-1B Tuba1b 50.55 2 17
P05214 Tubulin, alpha-3 Tuba3a 42.44 1 14
P68368 Tubulin, alpha-4A Tuba4a 46.43 3 16
Q9JJZ2 Tubulin, alpha-8 Tuba8 34.52 2 11
P68372 Tubulin, beta-4B Tubb4b 61.12 3 18
P99024 Tubulin, beta-5 Tubb5 61.26 4 18
Q922F4 Tubulin, beta-6 Tubb6 25.95 2 9
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of rounded fibres with differing diameter, fibre degeneration 
and inflammation, as well as the drastic reduction in the 
sarcolemmal expression of full-length dystrophin isoform 
Dp427-M, were confirmed by haematoxylin/eosin stain-
ing (Fig. 3a, d) and immunofluorescence microscopy of 
transverse cryo-sections (Fig. 3b, e). The systematic mass 
spectrometric survey of the Dp427-deficient diaphragm 
muscle revealed 289 decreased and 468 increased protein 
species. The top 40 proteomic hits of decreased versus 
increased proteins are listed in Tables 5 and 6, respectively. 
The remaining proteins with a changed abundance in mus-
cular dystrophy are listed in the supplementary material as 
Table S1 and Table S2. A heatmap for the 516 differentially 
abundant proteins with greater than/equal to twofold change 
is shown in Fig. 4. The drastic reduction in dystrophin iso-
form Dp427-M confirmed the mutant status of the mdx-4cv 
diaphragm used in this study, and the concomitant change 
in dystrophin-associated proteins was also verified for 
α1-syntrophin, α-sarcoglycan, β-sarcoglycan, δ-sarcoglycan 
and dystroglycan.
Interesting marker proteins with a drastically decreased 
concentration due to dystrophin deficiency were identified 
as enzymes and metabolite transporters of oxidative metab-
olism such as NADH dehydrogenase, fatty acid binding 
Table 3  Proteomic map of the 
basal lamina and extracellular 
matrix from diaphragm muscle
Accession Protein name Gene name Coverage % Unique 
Peptides
Peptides
Q3V3R4 Integrin, alpha-1 Itga1 5.00 5 5
Q61739 Integrin, alpha-6 Itga6 2.52 2 2
Q61738 Integrin, alpha-7 Itga7 10.93 9 9
P09055 Integrin, beta-1 Itgb1 10.03 6 6
Q60675 Laminin, alpha-2 Lama2 23.41 56 56
P97927 Laminin, alpha-4 Lama4 11.95 15 15
Q61001 Laminin, alpha-5 Lama5 2.77 8 8
P02469 Laminin, beta-1 Lamb1 13.49 22 22
Q61292 Laminin, beta-2 Lamb2 17.12 24 24
P02468 Laminin subunit gamma-1 Lamc1 20.66 27 27
Q05793 Basement membrane-specific heparan 
sulfate proteoglycan core protein
Hspg2 17.51 42 42
P11087 Collagen alpha-1(I) Col1a1 6.74 7 7
Q01149 Collagen alpha-2(I) Col1a2 14.14 14 14
P08121 Collagen alpha-1(III) Col3a1 3.01 3 3
P08122 Collagen alpha-2(IV) Col4a2 2.05 3 3
Q3U962 Collagen alpha-2(V) Col5a2 1.94 2 2
Q04857 Collagen alpha-1(VI) Col6a1 28.00 20 20
Q02788 Collagen alpha-2(VI) Col6a2 23.69 21 21
A6H584 Collagen alpha-5(VI) Col6a5 15.76 26 30
Q8C6K9 Collagen alpha-6(VI) Col6a6 21.63 28 32
Q60847 Collagen alpha-1(XII) Col12a1 24.70 51 51
Q80 × 19 Collagen alpha-1(XIV) Col14a1 1.80 2 2
O35206 Collagen alpha-1(XV) Col15a1 10.75 9 9
P10493 Nidogen-1 Nid1 24.90 20 21
O88322 Nidogen-2 Nid2 7.48 7 8
Q62000 Mimecan Ogn 28.52 7 7
P28654 Decorin Dcn 30.79 9 10
Q9JK53 Prolargin Prelp 34.13 12 12
P50608 Fibromodulin Fmod 22.87 8 8
Q9QZZ6 Dermatopontin Dpt 9.45 2 2
P29788 Vitronectin Vtn 6.28 2 2
P11276 Fibronectin Fn1 17.04 23 23
Q62009 Periostin Postn 15.07 8 8
P28653 Biglycan Bgn 32.25 9 10
P51885 Lumican Lum 29.88 8 8
Q99MQ4 Asporin Aspn 31.64 9 9
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protein FABP3 and the oxygen-transporter myoglobin, the 
glycolytic enzymes phosphofructokinase, the  Ca2+-binding 
protein parvalbumin, isoforms PLIN3 and PLIN5 of the 
lipid droplet-associated protein perilipin, the Z-disk protein 
myozenin-2, carbonic anhydrase CA3 and adenylate kinase 
AK1, as well as a broad spectrum of metabolic enzymes, 
structural components and signalling proteins (Table 5, 
Table S1). The decreased concentration of carbonic anhy-
drase CA3 was confirmed by comparative immunofluores-
cence microscopy (Fig. 3c, f).
An intriguing finding is the apparent switch of phospho-
glycerate mutase isoforms between isozyme PGAM2 and 
isozyme PGMA1. The two isoforms of this key glycolytic 
enzyme mediate the interconversion of 3-phosphoglycer-
ate and 2-phosphoglycerate. X-linked muscular dystrophy 
appears to be associated with a drastic reduction in the 
muscle-specific PGAM-M form and concomitant increase in 
the ubiquitous form of this enzyme (Tables 5, 6). The large 
number of increased diaphragm proteins included a variety 
of potential marker candidates of dystrophic changes, includ-
ing cytochrome P450 isoforms 2C70 and 3A13, myosin-3 
and the perinatal isoform of myosin heavy chain (myosin-8), 
the intermediate filament protein nestin, the extracellular 
matrix components vitronectin and tenascin, and the matri-
cellular protein periostin (Table 6, Table S2).
Bioinformatics using publically available database 
searches was employed to analyse the clustering of changes 
in relation to protein classes and potential alterations in 
interaction patterns of diaphragm proteins involved in energy 
metabolism, the contractile apparatus, proteostasis and the 
extracellular matrix. The comparative PANTHER analy-
sis (http://ww.panth erdb.org) presented in supplementary 
Figure S1 illustrates considerable concentration changes in 
diaphragm proteins belonging to the class of cytoskeletal 
components, transferases, oxidoreductases, hydrolases and 
enzyme modulators. There is a striking increase in nucleic 
Table 4  Proteomic map of the excitation–contraction coupling and ion-handling apparatus from diaphragm muscle
Accession Protein name Gene name Coverage % Unique 
Peptides
Peptides
E9PZQ0 Ryanodine receptor 1 Ryr1 34.40 125 125
Q02789 Voltage-dependent L-type calcium channel, alpha-1S Cacna1s 8.92 14 14
O08532 Voltage-dependent calcium channel, alpha-2/delta-1 Cacna2d1 28.14 25 25
Q8R3Z5 Voltage-dependent L-type calcium channel subunit beta-1 Cacnb1 25.70 13 13
O09165 Calsequestrin-1 Casq1 52.10 15 15
O09161 Calsequestrin-2 Casq2 34.70 10 10
Q7TQ48 Sarcalumenin Srl 43.85 29 29
Q64374 Regucalcin Rgn 27.09 7 7
P0DP28 Calmodulin-3 Calm3 62.42 9 10
P11798 Calcium/calmodulin-dependent protein kinase type II, alpha Camk2a 12.34 2 4
P28652 Calcium/calmodulin-dependent protein kinase type II, beta Camk2b 18.82 4 7
Q6PHZ2 Calcium/calmodulin-dependent protein kinase type II, delta Camk2d 14.44 2 5
Q923T9 Calcium/calmodulin-dependent protein kinase type II, gamma Camk2g 12.53 2 5
P56565 Protein S100-A1 S100a1 29.79 2 2
P08207 Protein S100-A10 S100a10 27.84 2 2
E9Q9K5 Triadin Triadin 16.74 12 12
Q9ET80 Junctophilin-1 Jph1 23.18 11 11
Q9ET78 Junctophilin-2 Jph2 20.83 12 12
Q3MI48 Junctional sarcoplasmic reticulum protein 1 Jsrp1 35.24 7 7
Q8BZ71 SH3 and cysteine-rich domain-containing protein STAC3 Stac3 22.50 6 6
P70302 Stromal interaction molecule 1 Stim1 15.91 8 8
Q8R429 Calcium ATPase SERCA1 Atp2a1 47.89 35 51
O55143-2 Calcium ATPase SERCA2 Atp2a2 41.08 24 40
G5E829 Plasma membrane calcium-transporting ATPase 1 Atp2b1 4.34 3 4
Q6Q477-2 Plasma membrane calcium-transporting ATPase 4 Atp2b4 2.98 1 2
Q9ER60 Sodium channel type 4, alpha Scn4a 1.63 2 2
Q8VDN2 Sodium/potassium-ATPase, alpha-1 Atp1a1 33.04 18 30
Q6PIE5 Sodium/potassium-ATPase, alpha-2 Atp1a2 41.57 26 38
P14094 Sodium/potassium-ATPase, beta-1 Atp1b1 28.95 6 6
19Journal of Muscle Research and Cell Motility (2019) 40:9–28 
1 3
acid binding proteins due to deficiency in dystrophin. An 
overview of reduced versus increased protein classes in rela-
tion to cellular component, molecular function and biologi-
cal process in the dystrophic mdx-4cv mouse diaphragm is 
diagrammatically presented in Figs. 5 and 6, respectively. 
Shown are the most enriched GO terms for changed dia-
phragm proteins.
Dystrophinopathy-associated changes in functional pro-
tein association networks were determined by STRING 
analysis (https ://strin g-db.org) and confirmed significant 
decreases in the dystrophin–glycoprotein complex and pro-
tein hubs involved in mitochondrial metabolism and fatty 
acid utilization, as well as glucose metabolism (Fig. 7). 
The abundance of a large number of subunits of the mito-
chondrial NADH dehydrogenase complex were shown to 
be reduced in dystrophic diaphragm. These effects on the 
expression levels of the NADH dehydrogenase, as well as 
succinate dehydrogenase, cytochrome-c reductase and ATP 
synthase, are illustrated in Figure S2. This supplementary 
figure shows the KEGG search and colour pathway analy-
sis (Kyoto Encyclopedia of Genes and Genomes; https ://
www.genom e.jp/kegg) of the dystrophic mdx-4cv diaphragm 
focusing on oxidative phosphorylation, and is based on a 
dataset of 289 decreased proteins of which 28 protein spe-
cies were found in the oxidative phosphorylation pathway.
Proteins that are associated with the contractile apparatus 
were shown to undergo considerable changes in abundance, 
isoform expression levels and interaction patterns. The com-
parative STRING analysis of decreased versus increased 
contractile proteins revealed changes especially in myosin 
heavy chains, troponins and tropomyosin (Figs. 7, 8). Protein 
hubs with increased proteins were found to be linked to RNA 
processing, ribosomes, the proteasome, the cytochrome 
P450 complex and the Golgi apparatus. In agreement with 
elevated cellular stress levels and reactive myofibrosis in 
the dystrophin-deficient diaphragm, the findings from the 
STRING analysis presented in Fig. 8 indicates an apparent 
up-regulation of extracellular matrix proteins and molecular 
chaperones.
Discussion
As the main skeletal muscle involved in respiration, the 
proper functioning and physiological adaptation of the 
thoracic diaphragm is crucial for whole body homeosta-
sis (Bordoni and Zanier 2013; Kocjan et al. 2017). In the 
past, histochemical, immunochemical and biochemical 
methods have been used to study the distribution and fibre 
type-specific expression patterns of muscle marker proteins 
A   H&E  mdx-4cv B Dp427  mdx-4cv C   CA3  mdx-4cv
D   H&E  wild type E Dp427  wild type F CA3  wild type
Fig. 3  Histological and immunofluorescence microscopical charac-
terization of the dystrophic mdx-4cv diaphragm muscle. Shown are 
transverse tissue sections of 12-month dystrophic mdx-4cv (a–c) ver-
sus wild type (d–f) diaphragm specimens, stained with haematoxy-
lin/eosin (a, d) or labelled with antibodies to the dystrophin isoform 
Dp427 (b, e) and the CA3 isoform of carbonic anhydrase (c, f). Mag-
nification bar equals 50 µm
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Table 5  Mass spectrometric identification of proteins with a reduced abundance in the dystrophic mdx-4cv diaphragm
Listed are the top 40 proteomic hits with significant concentration changes in dystrophin-deficient muscle tissue, established with the help of an 
Orbitrap Fusion Tribrid mass spectrometer. In addition, mass spectrometrically identified diaphragm proteins in the positions 41–289 are listed 
in Supplementary Table S1
Accession Protein name Gene name Unique 
peptides
Confidence score Anova (p) Fold change
Q8BK30 NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochon-
drial
Ndufv3 2 7.8638 1.56E−04 − 102.33
P70266 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Pfkfb1 2 6.4705 8.94E−07 − 14.07
P11404 Fatty acid-binding protein, heart Fabp3 3 13.5990 1.97E−08 − 14.01
P32848 Parvalbumin alpha Pvalb 4 12.1287 5.58E−10 − 13.99
P11531 Dystrophin Dp427-M Dmd 40 153.9807 5.19E−13 − 12.50
Q9JLV1 BAG family molecular chaperone regulator 3 Bag3 2 7.4879 6.95E−08 − 8.73
Q8BVZ1 Perilipin-5 Plin5 2 6.5124 7.47E−06 − 8.66
P70236 Dual specificity mitogen-activated protein kinase kinase 6 Map2k6 2 7.5185 1.87E−08 − 8.08
P28650 Adenylosuccinate synthetase isozyme 1 Adssl1 4 17.2037 1.51E−04 − 7.95
Q8VCF0 Mitochondrial antiviral-signaling protein Mavs 3 12.5693 1.24E−07 − 7.87
O70250 Phosphoglycerate mutase 2 Pgam2 2 8.0247 7.10E−07 − 7.45
Q9DBG5 Perilipin-3 Plin3 4 15.7082 1.31E−08 − 7.44
Q61234 Alpha-1-syntrophin Snta1 4 11.9300 3.02E−09 − 6.87
O88492 Perilipin-4 Plin4 9 28.2648 1.31E−09 − 6.84
P04247 Myoglobin Mb 7 31.6075 1.81E−05 − 6.56
A3KG59 Peptidase M20 domain-containing protein 2 Pm20d2 2 7.0814 1.14E−05 − 6.54
P82350 Alpha-sarcoglycan Sgca 3 9.9284 6.08E−06 − 6.21
Q149B8 PGC-1 and ERR-induced regulator in muscle protein 1 Perm1 3 10.2636 2.36E−05 − 6.18
Q9JJW5 Myozenin-2 Myoz2 4 14.02387 2.29E−05 − 6.10
Q9ET78 Junctophilin-2 Jph2 2 5.0768 2.26E−02 − 5.89
Q8K1Z0 Ubiquinone biosynthesis protein COQ9, mitochondrial Coq9 2 8.1729 6.61E−05 − 5.85
Q8BH86 D-glutamate cyclase, mitochondrial 1 SV 2 11.7460 3.31E−05 − 5.07
Q9R0Y5 Adenylate kinase isoenzyme 1 Ak1 3 16.4163 1.32E−05 − 4.78
Q9ET80 Junctophilin-1 Jph1 2 6.1080 3.79E−04 − 4.76
Q9D172 ES1 protein homolog, mitochondrial D10Jhu81e 4 10.9255 1.44E−06 − 4.61
Q99MR9 Protein phosphatase 1 regulatory subunit 3A Ppp1r3a 4 18.3577 1.23E−04 − 4.55
E9QA62 Leiomodin-3 Lmod3 3 9.2948 1.28E−07 − 4.38
Q5SX39 Myosin-4 Myh4 15 69.7577 4.62E−06 − 4.26
Q9WUR9 Adenylate kinase 4, mitochondrial Ak4 3 9.3956 7.30E−05 − 4.25
Q99NB1 Acetyl-coenzyme A synthetase 2-like, mitochondrial Acss1 3 13.5025 1.07E−04 − 4.23
P07310 Creatine kinase M-type Ckm 11 53.1162 2.97E−07 − 4.22
Q811I0 ATP synthase mitochondrial F1 complex assembly factor 1 Atpaf1 2 6.9054 4.60E−05 − 4.22
Q9DC69 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subu-
nit 9, mitochondrial
Ndufa9 2 5.8310 3.53E−08 − 4.10
Q99LM3 Smoothelin-like protein 1 Smtnl1 2 8.2936 3.77E−05 − 4.08
Q8VCR8 Myosin light chain kinase 2, skeletal/cardiac muscle Mylk2 2 6.7668 1.39E−06 − 4.02
P23506-2 Isoform 2 of Protein-L-isoaspartate(D-aspartate) O-methyl-
transferase
Pcmt1 2 6.9031 1.28E−04 − 3.92
Q8CC35 Synaptopodin Synpo 2 5.3858 2.72E−07 − 3.89
P12367 cAMP-dependent protein kinase type II-alpha regulatory 
subunit
Prkar2a 2 7.6514 2.30E−02 − 3.89
P16015 Carbonic anhydrase 3 Ca3 2 12.7933 7.36E−04 − 3.86
Q9DCW4 Electron transfer flavoprotein subunit beta Etfb 4 13.6339 2.12E−06 − 3.76
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during development, maturation and aging of this special-
ized type of contractile tissue (Agbulut et al. 2003; Geiger 
et al. 2006; Greising et al. 2015). Building on these studies 
and to verify the presence of key muscle protein isoforms by 
mass spectrometry, this report outlines the findings from the 
systematic survey of total extracts from mouse diaphragm 
using an Orbitrap Fusion Tribrid mass spectrometer. The 
establishment of an initial reference map of the experimen-
tally assessable diaphragm proteome revealed an interest-
ing constellation of myosin heavy chains and associated 
Table 6  Mass spectrometric identification of proteins with an increased abundance in the dystrophic mdx-4cv diaphragm
Listed are the top 40 proteomic hits with significant concentration changes in dystrophin-deficient muscle tissue, established with the help of an 
Orbitrap Fusion Tribrid mass spectrometer. In addition, mass spectrometrically identified diaphragm proteins in the positions 41–468 are listed 
in supplementary Table S2
Accession Protein name Gene name Unique 
peptides
Confidence score Anova (p) Fold change
Q91W64 Cytochrome P450 2C70 Cyp2c70 2 5.2815 2.20E−02 Infinity
O35423 Serine–pyruvate aminotransferase, mitochondrial Agxt 2 5.13381 4.36E−03 224.53
Q9DBJ1 Phosphoglycerate mutase 1 Pgam1 2 10.2674 2.21E−03 195.52
Q8BU30 Isoleucine–tRNA ligase, cytoplasmic Iars 2 4.6829 3.67E−04 70.96
P13542 Myosin-8 Myh8 10 41.2730 1.95E−11 57.09
Q920E5 Farnesyl pyrophosphate synthase Fdps 3 10.3610 5.81E−03 44.57
Q640N1 Adipocyte enhancer-binding protein 1 Aebp1 4 13.0625 4.81E−08 44.23
Q64464 Cytochrome P450 3A13 Cyp3a13 2 5.7456 2.40E−02 43.98
P29788 Vitronectin Vtn 2 8.2586 9.52E−07 41.9
Q922D8 C-1-tetrahydrofolate synthase, cytoplasmic Mthfd1 2 7.8328 2.29E−02 38.15
Q920A5 Retinoid-inducible serine carboxypeptidase Scpep1 2 4.8029 3.30E−03 37.77
Q9CW42 Mitochondrial amidoxime-reducing component 1 Marc1 2 4.9948 2.04E−03 33.6
Q9DD20 Methyltransferase-like protein 7B Mettl7b 2 5.7890 2.03E−05 27.17
O35841 Apoptosis inhibitor 5 Api5 2 8.7338 1.14E−04 23.45
Q6P5H2 Nestin Nes 3 10.1586 1.91E−09 23.44
Q91 × 91 Nicotinate-nucleotide pyrophosphorylase [carboxylating] Qprt 2 4.6746 2.42E−02 22.58
Q80YX1 Tenascin Tnc 2 7.0335 7.48E−08 21.63
P05784 Keratin, type I cytoskeletal 18 Krt18 3 10.7953 5.88E−03 17.86
Q64674 Spermidine synthase Srm 2 7.07431 7.38E−03 17.58
Q8BH97 Reticulocalbin-3 Rcn3 4 11.3589 3.83E−07 17.55
Q9DBF1 Alpha-aminoadipic semialdehyde dehydrogenase Aldh7a1 2 7.1164 1.58E−02 16.1
P16110 Galectin-3 Lgals3 2 8.9432 8.12E−09 16.08
Q91YI0 Argininosuccinate lyase Asl 2 5.1020 1.77E−03 15.53
Q62009 Periostin Postn 8 27.5746 1.11E−11 15.26
Q9QZD8 Mitochondrial dicarboxylate carrier Slc25a10 2 4.1041 7.83E−03 14.95
Q64435 UDP-glucuronosyltransferase 1–6 Ugt1a6 2 7.4589 8.84E−04 14.58
Q91XD4 Formimidoyltransferase-cyclodeaminase Ftcd 2 5.2185 1.22E−03 13.29
Q80 × 19 Collagen alpha-1(XIV) chain Col14a1 3 7.4739 1.65E−02 13.25
P13541 Myosin-3 Myh3 19 80.7618 1.54E−10 12.93
Q80UM7 Mannosyl-oligosaccharide glucosidase Mogs 3 8.9233 5.99E−05 12.9
Q9R0H0 Peroxisomal acyl-coenzyme A oxidase 1 Acox1 3 10.7203 9.07E−03 12.51
P97872 Dimethylaniline monooxygenase [N-oxide-forming] 5 Fmo5 4 10.5899 3.38E−02 12.3
P09470 Angiotensin-converting enzyme Ace 2 8.4918 2.82E−09 11.9
Q8R164 Valacyclovir hydrolase Bphl 2 7.2247 4.48E−03 11.86
Q8CFX1 GDH/6PGL endoplasmic bifunctional protein H6pd 2 6.7554 9.00E−04 11.84
Q99PV0 Pre-mRNA-processing-splicing factor 8 Prpf8 4 12.9865 3.56E−04 11.77
P97501 Dimethylaniline monooxygenase [N-oxide-forming] 3 Fmo3 2 4.9013 1.99E−03 11.26
P09541 Myosin light chain 4 Myl4 3 9.7528 2.12E−05 11.03
O08601 Microsomal triglyceride transfer protein large subunit Mttp 3 9.6687 2.41E−02 10.66
Q4U4S6 Xin actin-binding repeat-containing protein 2 Xirp2 7 23.4318 7.44E−09 10.52
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contractile proteins, as well as key components of the extra-
sarcomeric cytoskeleton. Another focus of this study was on 
the protein constituents of the excitation–contraction cou-
pling apparatus and associated  Ca2+-handling components, 
and the main structural elements of the extracellular matrix 
of skeletal muscle fibres.
The diaphragm contains a mixture of slow and fast fibres, 
which reflects the differential need of predominantly slow 
Fig. 4  Label-free quantitative 
proteomic analysis of wild-type 
versus mdx-4cv diaphragm. 
Depicted is the result from 
hierarchical clustering of the 
mean protein expression values 
of 516 statistically significant 
differentially abundant proteins, 
performed using Perseus soft-
ware. Hierarchical clustering 
of z-score normalised intensity 
values illustrates diagrammati-
cally the alterations in protein 
abundance between wild-type 
and mdx-4cv diaphragm muscle
Fig. 5  Overview of reduced 
protein classes in relation to 
cellular component, molecular 
function and biological process 
in the dystrophic mdx-4cv 
mouse diaphragm. Shown are 
the most enriched GO terms 
for proteins with > twofold 
decreased abundance. Fold 
enrichment values are relative 
to random expression. For the 
enrichment values the mini-
mum number of genes for the 
corresponding term was set to 
5, EASE threshold was set to 
p 0.05, and Benjamini scores 
0.05. Shown in light grey are 
the six most enriched cellular 
component GO terms, in dark 
grey are the six most enriched 
molecular function GO terms 
and in black are the six most 
enriched biological process GO 
terms 0 10 20 30 40 50 60
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fibre contraction during periods of moderate breathing ver-
sus the increased recruitment of fast fibres during elevated 
breathing (Polla et al. 2004). On the cellular and molecular 
level, the heterogeneous fibre type composition of normal 
diaphragm muscle and fibre changes during development, 
adaptation, disuse, hypoxia, disease or aging can be conveni-
ently assessed by standardized histochemical or immunohis-
tochemical staining procedures, as well as the biochemical 
measurement of myosin heavy chain isoform expression lev-
els (Geiger et al. 2006; Greising et al. 2015; Hussain et al. 
2016). In rodents, the proportion of fast fibres is higher in 
respiratory muscles as compared to humans, probably due 
to varying ventilation rates in differently sized mammalian 
organisms (Lieberman et al. 1973; Mizuno 1991). In 90 day 
old mice, myosin heavy chain isoforms were shown to exist 
as fast isoforms MyHC-IIA, MyHC-IIX/IID and MyHC-IIB, 
and the slow isoform MyHC-I/β (Agbulut et al. 2003). The 
proteomic profiling of normal diaphragm muscle corrobo-
rates the complexity of myosin expression levels of the thick 
filament and showed the presence of myosin heavy chains 
myosin-1 (MyHC-2x), myosin-3 (MyHC-3), myosin-4 
(MyHC-2b), myosin-7 (MyHC-slow) and myosin-8 (MyHC-
perinatal), as well as the myosin light chains MLC1/MLC3, 
MLC2 (muscle), MLC2 (slow) and MLC3 (slow) (Holland 
and Ohlendieck 2013). The presence of the main α-actin 
component of the thin filament and its associated regula-
tory troponin and tropomyosin complexes, and the listing 
of auxiliary sarcomeric proteins such as α-actinins, filamin, 
ankyrins, telethonin, myomesins and myozenins confirmed 
the bioanalytical sensitivity of the proteomic approach.
Notable mass spectrometric identifications are that of the 
extremely large proteins titin and obscurin by 1299 and 157 
unique peptides, respectively. Titin is the largest mamma-
lian protein with a molecular mass of approximately 3–4 
MDa and spans half the sarcomere structure in muscle fibres 
(Krüger and Kötter 2016). Proteins of this size can usually 
not be analysed by routine two-dimensional gel electropho-
resis, so this finding demonstrates the advantage of liquid 
chromatography as a protein separation technique for study-
ing giant muscle protein species (Deshmukh et al. 2015). 
The bioanalytical challenges encountered during the sys-
tematic separation and identification of large muscle proteins 
using gel-based methods versus liquid chromatography dur-
ing proteomic screening studies have been recently reviewed 
(Murphy et al. 2019a). Proteomic approaches with a focus 
on giant protein species and large protein complexes, such 
as protein assemblies within the sarcomere, the cytoskeleton 
and the sarcoplasmic reticulum, have mostly been studied 
using liquid chromatography, but can also be carried out 
by one-dimensional gel electrophoresis and the GeLC-MS 
method (Murphy and Ohlendieck 2018). The same technical 
issue is relevant for the routine proteomic analysis of a vari-
ety of extra-sarcomeric proteins, ion channels and extracel-
lular matrix proteins. In this study, the full-length dystrophin 
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Fig. 6  Overview of increased protein classes in relation to cellular 
component, molecular function and biological process in the dys-
trophic mdx-4cv mouse diaphragm. Shown are the most enriched GO 
terms for proteins with > twofold increased abundance. Fold enrich-
ment values are relative to random expression. For the enrichment 
values the minimum number of genes for the corresponding term 
was set to 5, EASE threshold was set to p 0.05, and Benjamini scores 
0.05. Shown in light grey are the six most enriched cellular com-
ponent GO terms, in dark grey are the six most enriched molecular 
function GO terms and in black are the six most enriched biological 
process GO terms
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isoform Dp427-M and the large cytoskeletal protein plectin 
were detected by 90 and 213 unique peptides, respectively, 
which presents an excellent sequence coverage of these high-
molecular-mass components. These results demonstrate that 
the LC–MS/MS approach using an Orbitrap Fusion Tribrid 
mass spectrometer is suitable for the detailed evaluation of 
the various components of the intracellular cytoskeletal net-
work of contractile fibres, such as tubulins, actins, vinculin, 
desmin, vimentin and synemin (Henderson et al. 2017).
The sequence of large proteins of the basal lamina and the 
extracellular matrix, such as laminin, the basement mem-
brane-specific heparan sulfate proteoglycan core protein, 
collagens and fibronectin was also well covered by the prot-
eomic analysis of normal diaphragm muscle, which is a pre-
requisite for proper comparative studies of skeletal muscle 
fibrosis (Holland et al. 2016). The large ryanodine receptor 
 Ca2+-release channel of the sarcoplasmic reticulum (Santulli 
et al. 2017) and key proteins of the highly complex network 
of  Ca2+-regulatory proteins, such as the various subunits of 
the voltage-dependent L-type  Ca2+-channel,  Ca2+-ATPases, 
luminal and cytosolic  Ca2+-binding proteins,  Ca2+-shuttle 
proteins and other ion-handling components were also 
identified, demonstrating the usefulness of this proteomic 
approach for the detailed analysis of potential changes in the 
excitation–contraction coupling apparatus during skeletal 
muscle adaptations or pathophysiological processes.
The progressive respiratory decline in many neuromus-
cular disorders of childhood (Buu 2017) warrants detailed 
studies into the molecular mechanisms of diaphragm abnor-
malities such as seen in Duchenne muscular dystrophy 
Fig. 7  Bioinformatics analysis of potential interaction patterns of 
decreased proteins in the dystrophic mdx-4cv mouse diaphragm. The 
bioinformatics software programme STRING was used to summa-
rize interaction hubs by proteins with a decreased concentration in 
the mdx-4cv mouse diaphragm. The mutant status of the investigated 
muscle was confirmed by the drastic reduction in the dystrophin–
glycoprotein complex. Other protein clusters, such as the contractile 
apparatus, NADH dehydrogenase, and enzyme complexes involved in 
glucose and oxidative metabolism, are marked
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(Khirani et al. 2014). Building on the initial establishment 
of the proteomic map of the normal diaphragm, this report 
outlines the suitability of comparative proteomic analyses 
for the unequivocal identification of proteome-wide changes 
due to deficiency in the membrane cytoskeletal protein dys-
trophin. The refined proteomic profiling of the mdx-4cv dia-
phragm using a highly sensitive mass spectrometer revealed 
a wider scope of considerable differential changes in the 
contractile apparatus, the extra-sarcomeric cytoskeleton, the 
extracellular matrix and excitation–contraction coupling pro-
teins, as previously reported. In contrast to the already pub-
lished proteomic maps of the dystrophic diaphragm (Doran 
et al. 2006, 2009; Carberry et al. 2012; Matsumura et al. 
2013; Holland et al. 2015a, b), the new dataset of identified 
proteins with a changed concentration due to dystrophic and 
fibrotic changes is more comprehensive, and shows detailed 
alterations in a large number of pathways and protein hubs 
(Holland et al. 2013; Fuller et al. 2016).
Expression changes in MyHC isoforms in the dystrophic 
diaphragm were previously determined by gel electropho-
retic analysis and immunofluorescence microscopy and 
indicated age-related differences in fibre type specification 
(Petrof et al. 1993; Coirault et al. 1999; Muller et al. 2001). 
The overall trend of isoform shifting agrees with the mass 
spectrometric findings presented in this report. The prot-
eomic identification of increases in myosin-3 (MyHC-3), 
myosin-7 (MyHC-slow) and myosin-8, the perinatal iso-
form of myosin heavy chain, which is indicative of fibre 
regeneration processes, agrees with previous analyses of 
MyHC changes in the mdx diaphragm (Petrof et al. 1993). 
The reported drastic decrease in the IIx/b fiber population 
during maturation of the mdx diaphragm (Petrof et al. 1993; 
Coirault et al. 1999) was also confirmed by the new prot-
eomic dataset on the 10-month old mdx-4cv diaphragm that 
showed a reduced concentration of myosin-4 (MyHC-2b) 
and myosin-1 (MyHC-2x), as well as myosin light chains 2 
Fig. 8  Bioinformatics analysis of potential interaction patterns of 
increased proteins in the dystrophic mdx-4cv mouse diaphragm. The 
bioinformatics software programme STRING was used to summa-
rize interaction hubs of proteins with an increased concentration in 
the mdx-4cv mouse diaphragm. Protein clusters involved in ribosomal 
function, the proteasome, the cytochrome P450 complex, the Golgi 
apparatus, the extracellular matrix, the contractile apparatus, and the 
cellular stress response are marked
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and 1/3 and myosin-binding protein MBP-C. The decrease 
in several isoforms of the M-band protein myomesin and 
Z-disk component myozenin, as well as the observed up-
regulation of the extra-sarcomeric cytoskeletal proteins 
vimentin and tubulins, is in agreement with previous pro-
teomic studies (Holland et al. 2015a; Murphy et al. 2015a).
A central pathophysiological mechanism involved in pro-
gressive skeletal muscle degeneration is based on high lev-
els of  Ca2+-influx through sarcolemmal  Ca2+-leak channels, 
which triggers elevated levels of  Ca2+-dependent proteolysis 
in dystrophin-deficient fibres (Hopf et al. 2007) and impaired 
 Ca2+-buffering in the lumen of the sarcoplasmic reticulum 
(Culligan et  al. 2002). Stretch-activated  Ca2+-channels 
are believed to play a central role in the generation of the 
dystrophic phenotype (Matsumura et al. 2011). High cyto-
solic  Ca2+-levels have a modifying effect on the rate of 
 Ca2+-release and -reuptake (DeLuca et al. 1998) and thereby 
change the excitation–contraction coupling mechanism in 
dystrophic fibres (Mázala et al. 2015). The idea of impaired 
coupling between sarcolemmal excitation,  Ca2+-release from 
the sarcoplasmic reticulum, physiological coupling to fibre 
contraction and subsequent relaxation-inducing reuptake 
of  Ca2+-ions from the cytosol agrees with the proteomic 
identification of a reduced abundance of key  Ca2+-handling 
proteins (Doran et al. 2004; Matsumura et al. 2013). As 
shown in this report, abnormal  Ca2+-homoestasis includes 
crucial regulators of the excitation–contraction-relaxation 
cycle, such as the core ryanodine receptor  Ca2+-release 
channel of the sarcoplasmic reticulum, the α-1S, α-2/δ-1 
and β-1subunits of the voltage-dependent  Ca2+-channel 
of the transverse tubules, the fast SERCA1 isoform of the 
 Ca2+-ATPase of the longitudinal tubules, and the fast CSQ-1 
and slow CSQ-2 isoforms of the luminal  Ca2+-binding pro-
tein calsequestrin of the terminal cisternae region (Hernán-
dez-Ochoa and Schneider 2018).
In addition to proteomic changes in markers of the con-
tractile apparatus, the cytoskeletal network and ion homeo-
stasis, elevated levels of a variety of components involved 
in the maintenance and stabilisation of the extracellu-
lar matrix, protein synthesis, fibre remodelling and the 
immune response were also identified in this report. This 
included increases in various collagen chains, fibronectin, 
biglycan, the matricellular protein periostin and proteo-
glycans of the extracellular matrix, and probably relates 
to reactive myofibrosis in dystrophic muscles (Holland 
et al. 2016; Murphy et al. 2017), especially affecting the 
endomysium and causing loss of fibre elasticity and motor 
function (Desguerre et al. 2009). In agreement with the 
recent proteomic profiling of the dystrophin-deficient 
sarcolemma membrane (Murphy et al. 2019b), increased 
levels of subunits of the histocompatibility complex, 
macrophage mannose receptor and annexins were shown 
to occur in the dystrophic mdx-4cv diaphragm. The ele-
vated concentration of the  Ca2+-triggered phospholipid-
binding isoform A1 of annexin is probably involved in 
plasmalemma wound-healing, but also in the restoration 
of cellular homeostasis by modulating the inflammatory 
response. This would agree with the concept that muscu-
lar dystrophy-specific inflammatory modifiers in the form 
of macrophages, neutrophils and T-lymphocytes amplify 
the degenerative phenotype in dystrophinopathies (Tidball 
et al. 2018). Differential effects on metabolic proteins were 
previously shown to occur in the mdx mouse (Rayavarapu 
et al. 2013; Murphy et al. 2015b; Gamberi et al. 2018) and 
were also shown to be a feature of the mdx-4cv diaphragm, 
including decreases in key enzymes of glucose metabo-
lism, fatty acid transportation and oxidative metabolism, 
such as the NADH dehydrogenase complex.
Conclusions
Using an Orbitrap Fusion Tribrid mass spectrometer, the 
experimentally assessable proteome of the mouse dia-
phragm was established, with special focus on marker 
proteins of the acto-myosin apparatus and its auxiliary 
components, the dystrophin–glycoprotein complex and 
its associated extra-sarcomeric cytoskeletal network, the 
 Ca2+-handling protein complex involved in the regulation 
of excitation–contraction coupling and muscle relaxation, 
and the extracellular matrix. The respiratory muscle pro-
teome was shown to contain a characteristic presence of a 
wide variety of myosin heavy and lights chains, reflecting 
its specialized function in active inspiration. Standardized 
bioinformatics was employed to establish the distribution 
of protein classes within the normal diaphragm proteome, 
as well as biological processes and subcellular localiza-
tion. The refined analysis of the mdx-4cv mouse model 
of X-linked muscular dystrophy revealed considerable 
changes in diaphragm-associated proteins involved in 
energy metabolism, the excitation–contraction-relaxation 
cycle, ion homeostasis, proteostasis, the cytoskeleton and 
the extracellular matrix. The pathoproteomic profile of 
the dystrophic diaphragm agrees with the idea that the 
almost complete loss of the membrane cytoskeletal protein 
dystrophin triggers complex changes in many key cellular 
processes, causing abnormal  Ca2+-signalling, contractile 
weakness, sterile inflammation and reactive myofibrosis.
Acknowledgements Research was supported by project grants from 
Muscular Dystrophy Ireland and the Irish Health Research Board 
(HRB/MRCG-2016-20) and a Hume scholarship from Maynooth Uni-
versity. The Orbitrap Fusion Tribrid mass spectrometer was funded 
under a Science Foundation Ireland Infrastructure Award to Dublin 
City University (SFI 16/RI/3701).
27Journal of Muscle Research and Cell Motility (2019) 40:9–28 
1 3
References
Agbulut O, Noirez P, Beaumont F, Butler-Browne G (2003) Myosin 
heavy chain isoforms in postnatal muscle development of mice. 
Biol Cell 95:399–406
Allen DG, Whitehead NP, Froehner SC (2016) Absence of dystrophin 
disrupts skeletal muscle signaling: roles of  Ca2+, reactive oxygen 
species, and nitric oxide in the development of muscular dystro-
phy. Physiol Rev 96:253–305
Bordoni B, Zanier E (2013) Anatomic connections of the diaphragm: 
influence of respiration on the body system. J Multidiscip Healthc 
6:281–291
Bradford MM (1976) A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle of 
protein-dye binding. Anal Biochem 72:248–254
Buu MC (2017) Respiratory complications, management and treat-
ments for neuromuscular disease in children. Curr Opin Pediatr 
29:326–333
Capitanio D, Moriggi M, Gelfi C (2017) Mapping the human skeletal 
muscle proteome: progress and potential. Expert Rev Proteomics 
14:825–839
Carberry S, Zweyer M, Swandulla D, Ohlendieck K (2012) Proteomics 
reveals drastic increase of extracellular matrix proteins collagen 
and dermatopontin in the aged mdx diaphragm model of Duch-
enne muscular dystrophy. Int J Mol Med 30:229–234
Chapman VM, Miller DR, Armstrong D, Caskey CT (1989) Recovery 
of induced mutations for X chromosome-linked muscular dystro-
phy in mice. Proc Natl Acad Sci USA 86:1292–1296
Coirault C, Lambert F, Marchand-Adam S, Attal P, Chemla D, Lecar-
pentier Y (1999) Myosin molecular motor dysfunction in dys-
trophic mouse diaphragm. Am J Physiol 277:C1170–C1176
Coirault C, Pignol B, Cooper RN, Butler-Browne G, Chabrier PE, 
Lecarpentier Y (2003) Severe muscle dysfunction precedes col-
lagen tissue proliferation in mdx mouse diaphragm. J Appl Physiol 
94:1744–1750
Culligan K, Banville N, Dowling P, Ohlendieck K (2002) Drastic 
reduction of calsequestrin-like proteins and impaired calcium 
binding in dystrophic mdx muscle. J Appl Physiol 92:435–445
De Luca A, Pierno S, Camerino C, Huxtable RJ, Camerino DC (1998) 
Effect of taurine on excitation-contraction coupling of extensor 
digitorum longus muscle of dystrophic mdx mouse. Adv Exp Med 
Biol 442:115–119
Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C 
(2009) Endomysial fibrosis in Duchenne muscular dystrophy: a 
marker of poor outcome associated with macrophage alternative 
activation. J Neuropathol Exp Neurol 68:762–773
Deshmukh AS, Murgia M, Nagaraj N, Treebak JT, Cox J, Mann M 
(2015) Deep proteomics of mouse skeletal muscle enables quan-
titation of protein isoforms, metabolic pathways, and transcription 
factors. Mol Cell Proteom 14:841–853
Doran P, Dowling P, Lohan J, McDonnell K, Poetsch S, Ohlendieck 
K (2004) Subproteomics analysis of  Ca2+-binding proteins dem-
onstrates decreased calsequestrin expression in dystrophic mouse 
skeletal muscle. Eur J Biochem 271:3943–3952
Doran P, Martin G, Dowling P, Jockusch H, Ohlendieck K (2006) 
Proteome analysis of the dystrophin-deficient MDX diaphragm 
reveals a drastic increase in the heat shock protein cvHSP. Prot-
eomics 6:4610–4621
Doran P, Wilton SD, Fletcher S, Ohlendieck K (2009) Proteomic 
profiling of antisense-induced exon skipping reveals reversal of 
pathobiochemical abnormalities in dystrophic mdx diaphragm. 
Proteomics 9:671–685
Dowling P, Murphy S, Ohlendieck K (2016) Proteomic profiling of 
muscle fibre type shifting in neuromuscular diseases. Expert Rev 
Proteom 13:783–799
Fuller HR, Graham LC, Llavero Hurtado M, Wishart TM (2016) 
Understanding the molecular consequences of inherited muscu-
lar dystrophies: advancements through proteomic experimenta-
tion. Expert Rev Proteom 13:659–671
Gamberi T, Fiaschi T, Valocchia E, Modesti A, Mantuano P, Rolland 
JF, Sanarica F, De Luca A, Magherini F (2018) Proteome analy-
sis in dystrophic mdx mouse muscle reveals a drastic alteration 
of key metabolic and contractile proteins after chronic exercise 
and the potential modulation by anti-oxidant compounds. J Pro-
teom 170:43–58
Geiger PC, Bailey JP, Mantilla CB, Zhan WZ, Sieck GC (2006) 
Mechanisms underlying myosin heavy chain expression dur-
ing development of the rat diaphragm muscle. J Appl Physiol 
101:1546–1555
Gonzalez-Freire M, Semba RD, Ubaida-Mohien Fabbri E, Scalzo 
P, Højlund K, Dufresne C, Lyashkov A, Ferrucci L (2017) The 
Human Skeletal Muscle Proteome Project: a reappraisal of the 
current literature. J Cachexia Sarcopenia Muscle 8:5–18
Greising SM, Medina-Martínez JS, Vasdev AK, Sieck GC, Mantilla 
CB (2015) Analysis of muscle fiber clustering in the diaphragm 
muscle of sarcopenic mice. Muscle Nerve 52:76–82
Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, 
Kunkel LM (2015) The pathogenesis and therapy of muscular 
dystrophies. Annu Rev Genom Hum Genet 16:281–308
Henderson CA, Gomez CG, Novak SM, Mi-Mi L, Gregorio CC (2017) 
Overview of the muscle cytoskeleton. Compr Physiol 7:891–944
Hernández-Ochoa EO, Schneider MF (2018) Voltage sensing mecha-
nism in skeletal muscle excitation-contraction coupling: coming 
of age or midlife crisis? Skelet Muscle 8:22
Højlund K, Yi Z, Hwang H, Lefort N, Flynn CR, Langlais P, Weintraub 
ST, Mandarino LJ (2008) Characterization of the human skeletal 
muscle proteome by one-dimensional gel electrophoresis and 
HPLC-ESI-MS/MS. Mol Cell Proteom 7:257–267
Holland A, Ohlendieck K (2013) Proteomic profiling of the contractile 
apparatus from skeletal muscle. Expert Rev Proteom 10:239–257
Holland A, Carberry S, Ohlendieck K (2013) Proteomics of the dys-
trophin-glycoprotein complex and dystrophinopathy. Curr Protein 
Pept Sci 14:680–697
Holland A, Dowling P, Meleady P, Henry M, Zweyer M, Mundegar RR, 
Swandulla D, Ohlendieck K (2015a) Label-free mass spectromet-
ric analysis of the mdx-4cv diaphragm identifies the matricellular 
protein periostin as a potential factor involved in dystrophinopa-
thy-related fibrosis. Proteomics 15:2318–2331
Holland A, Henry M, Meleady P, Winkler CK, Krautwald M, Brink-
meier H, Ohlendieck K (2015b) Comparative label-free mass 
spectrometric analysis of mildly versus severely affected mdx 
mouse skeletal muscles identifies annexin, lamin, and vimentin 
as universal dystrophic markers. Molecules 20:11317–11344
Holland A, Murphy S, Dowling P, Ohlendieck K (2016) Pathoprot-
eomic profiling of the skeletal muscle matrisome in dystrophi-
nopathy associated myofibrosis. Proteomics 16:345–366
Hopf FW, Turner PR, Steinhardt RA (2007) Calcium misregulation 
and the pathogenesis of muscular dystrophy. Subcell Biochem 
45:429–464
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH (2018) Advances 
in the diagnosis and management of cardiomyopathy in Duchenne 
muscular dystrophy. Neuromuscul Disord 28:711–716
Hussain SN, Cornachione AS, Guichon C, Al Khunaizi A, Leite Fde 
S, Petrof BJ, Mofarrahi M, Moroz N, de Varennes B, Goldberg 
P, Rassier DE (2016) Prolonged controlled mechanical ventila-
tion in humans triggers myofibrillar contractile dysfunction and 
myofilament protein loss in the diaphragm. Thorax 71:436–445
Ishizaki M, Suga T, Kimura E, Shiota T, Kawano R, Uchida Y, Uchino 
K, Yamashita S, Maeda Y, Uchino M (2008) Mdx respiratory 
impairment following fibrosis of the diaphragm. Neuromuscul 
Disord 18:342–348
28 Journal of Muscle Research and Cell Motility (2019) 40:9–28
1 3
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) 
KEGG: new perspectives on genomes, pathways, diseases and 
drugs. Nucleic Acids Res 45(D1):D353–D361
Kelley RC, McDonagh B, Ferreira LF (2018) Advanced aging causes 
diaphragm functional abnormalities, global proteome remodeling, 
and loss of mitochondrial cysteine redox flexibility in mice. Exp 
Gerontol 103:69–79
Khirani S, Ramirez A, Aubertin G, Boulé M, Chemouny C, Forin V, 
Fauroux B (2014) Respiratory muscle decline in Duchenne muscular 
dystrophy. Pediatr Pulmonol 49:473–481
Kocjan J, Adamek M, Gzik-Zroska B, Czyżewski D, Rydel M (2017) Net-
work of breathing. Multifunctional role of the diaphragm: a review. 
Adv Respir Med 85:224–232
Krüger M, Kötter S (2016) Titin, a central mediator for hypertrophic 
signaling, exercise-induced mechanosignaling and skeletal muscle 
remodeling. Front Physiol 7:76
Lieberman DA, Faulkner JA, Craig AB Jr, Maxwell LC (1973) Perfor-
mance and histochemical composition of guinea pig and human 
diaphragm. J Appl Physiol 34:233–237
LoMauro A, D’Angelo MG, Aliverti A (2017) Sleep disordered breathing 
in duchenne muscular dystrophy. Curr Neurol Neurosci Rep 17:44
Matsumura CY, Taniguti AP, Pertille A, Santo Neto H, Marques MJ 
(2011) Stretch-activated calcium channel protein TRPC1 is corre-
lated with the different degrees of the dystrophic phenotype in mdx 
mice. Am J Physiol Cell Physiol 301:C1344–C1350
Matsumura CY, Menezes de Oliveira B, Durbeej M, Marques MJ (2013) 
Isobaric tagging-based quantification for proteomic analysis: a com-
parative study of spared and affected muscles from mdx mice at the 
early phase of dystrophy. PLoS One 8(6):e65831
Mázala DA, Grange RW, Chin ER (2015) The role of proteases in exci-
tation-contraction coupling failure in muscular dystrophy. Am J 
Physiol Cell Physiol 308:C33–C40
Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, Thomas PD 
(2017) PANTHER version 11: expanded annotation data from Gene 
Ontology and Reactome pathways, and data analysis tool enhance-
ments. Nucleic Acids Res 45:D183–D189
Mizuno M (1991) Human respiratory muscles: fibre morphology and 
capillary supply. Eur Respir J 4:587–601
Muller J, Vayssiere N, Royuela M, Leger ME, Muller A, Bacou F, Pons 
F, Hugon G, Mornet D (2001) Comparative evolution of muscular 
dystrophy in diaphragm, gastrocnemius and masseter muscles from 
old male mdx mice. J Muscle Res Cell Motil 22:133–139
Murgia M, Nagaraj N, Deshmukh AS, Zeiler M, Cancellara P, Moretti 
I, Reggiani C, Schiaffino S, Mann M (2015) Single muscle fiber 
proteomics reveals unexpected mitochondrial specialization. EMBO 
Rep 16:387–395
Murphy S, Ohlendieck K (2015) The biochemical and mass spectromet-
ric profiling of the dystrophin complexome from skeletal muscle. 
Comput Struct Biotechnol J 14:20–27
Murphy S, Ohlendieck K (2018) Proteomic profiling of large myofibrillar 
proteins from dried and long-term stored polyacrylamide gels. Anal 
Biochem 543:8–11
Murphy S, Henry M, Meleady P, Zweyer M, Mundegar RR, Swandulla 
D, Ohlendieck K (2015a) Simultaneous pathoproteomic evaluation 
of the dystrophin-glycoprotein complex and secondary changes in 
the mdx-4cv mouse model of duchenne muscular dystrophy. Biol-
ogy (Basel) 4:397–423
Murphy S, Zweyer M, Mundegar RR, Henry M, Meleady P, Swandulla 
D, Ohlendieck K (2015b) Concurrent label-free mass spectrometric 
analysis of dystrophin isoform Dp427 and the myofibrosis marker 
collagen in crude extracts from mdx-4cv skeletal muscles. Pro-
teomes 3:298–327
Murphy S, Dowling P, Ohlendieck K (2016) Comparative skeletal muscle 
proteomics using two-dimensional gel electrophoresis. Proteomes 
4(3):E27
Murphy S, Brinkmeier H, Krautwald M, Henry M, Meleady P, 
Ohlendieck K (2017) Proteomic profiling of the dystrophin 
complex and membrane fraction from dystrophic mdx muscle 
reveals decreases in the cytolinker desmoglein and increases in the 
extracellular matrix stabilizers biglycan and fibronectin. J Muscle 
Res Cell Motil 38:251–268
Murphy S, Henry M, Meleady P, Ohlendieck K (2018) Utilization of 
dried and long-term stored polyacrylamide gels for the advanced 
proteomic profiling of mitochondrial contact sites from rat liver. 
Biol Methods Protoc 3(1):bpy008
Murphy S, Dowling P, Zweyer M, Swandulla D, Ohlendieck K (2019a) 
Proteomic profiling of giant skeletal muscle proteins. Expert Rev 
Proteom 16:241–256
Murphy S, Zweyer M, Henry M, Meleady P, Mundegar RR, Swandulla 
D, Ohlendieck K (2019b) Proteomic analysis of the sarcolemma-
enriched fraction from dystrophic mdx-4cv skeletal muscle. J Pro-
teom 191:212–227
O’Sullivan F, Keenan J, Aherne S, O’Neill F, Clarke C, Henry M, 
Meleady P, Breen L, Barron N, Clynes M, Horgan K, Doolan P, 
Murphy R (2017) Parallel mRNA, proteomics and miRNA expres-
sion analysis in cell line models of the intestine. World J Gastroen-
terol 23:7369–7386
Ohlendieck K, Swandulla D (2017) Molecular pathogenesis of Duchenne 
muscular dystrophy-related fibrosis. Pathologe 38:21–29
Parker KC, Walsh RJ, Salajegheh M, Amato AA, Krastins B, Sarracino 
DA, Greenberg SA (2009) Characterization of human skeletal 
muscle biopsy samples using shotgun proteomics. J Proteome Res 
8:3265–3277
Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, Kelly AM 
(1993) Adaptations in myosin heavy chain expression and con-
tractile function in dystrophic mouse diaphragm. Am J Physiol 
265:C834–C841
Polla B, D’Antona G, Bottinelli R, Reggiani C (2004) Respiratory muscle 
fibres: specialisation and plasticity. Thorax 59:808–817
Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grod-
ish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, 
Nagaraju K (2013) Identification of disease specific pathways using 
in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol 
Cell Proteom 12:1061–1073
Santulli G, Lewis DR, Marks AR (2017) Physiology and pathophysiology 
of excitation-contraction coupling: the functional role of ryanodine 
receptor. J Muscle Res Cell Motil 38:37–45
Smith LR, Meyer G, Lieber RL (2013) Systems analysis of biological 
networks in skeletal muscle function. Wiley Interdiscip Rev Syst 
Biol Med 5:55–71
Sollanek KJ, Burniston JG, Kavazis AN, Morton AB, Wiggs MP, Ahn 
B, Smuder AJ, Powers SK (2017) Global proteome changes in the 
rat diaphragm induced by endurance exercise training. PLoS One 
12:e0171007
Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, 
Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM (1991) 
The mdx mouse diaphragm reproduces the degenerative changes of 
Duchenne muscular dystrophy. Nature 352:536–539
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, 
Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C 
(2017) The STRING database in 2017: quality-controlled protein-
protein association networks, made broadly accessible. Nucleic 
Acids Res 45:D362–D368
Tidball JG, Welc SS, Wehling-Henricks M (2018) Immunobiology of 
inherited muscular dystrophies. Compr Physiol 8:1313–1356
Wiśniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal 
sample preparation method for proteome analysis. Nat Methods 
6:359–362
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
